NIH teams with Appistry on genetic analysis; GSK's VC unit backs digital pharmacy tool;

> Appistry is helping NIH commercialize the genetic analysis techniques it uses to diagnose very rare disorders. News

> The VC arm of GlaxoSmithKline ($GSK) has invested in a digital speciality pharmacy ordering platform. Item

> Merck ($MRK) is ending the use of chimpanzees in research but hasn't said whether computer simulations will be used instead. Piece | More from FierceBiotech Research

> The New York Genome Center is recruiting a senior director of research computing. Advert

> Qiagen ($QGEN) is looking to its bioinformatics acquisitions Ingenuity and CLC bio to drive growth in 2014. Transcript

> Sales at Parexel's ($PRXL) eClinical unit grew 30% in the second quarter, in part because of the acquisition of Liquent. Results

> An Alzheimer's group has Photoshopped pictures of Facebook ($FB) users into events they never attended to raise awareness of what it is like to live with the disease. Article

> Service provider Camargo has updated its IT system to make it easier for clients to access data. Release

> Europe-based Mundipharma Research is using BioClinica's CTMS. Item

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.